Global Sunitinib malate market Size study, by Type (Purity: >99%, Purity: >98%, Purity: >97%), by Application (Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor) and Regional Forecasts 2021-2027

BIZ4509217
200 Pages
June 2021
Pharmaceuticals

Download Sample Get Discount

Global Sunitinib malate market is valued at approximately XX in 2020 and is anticipated to grow with a healthy growth rate of more than XX over the forecast period 2021-2027. Sunitinib malate is a small-molecule medication that has been shown to block several tyrosine kinases in different receptors (RTKs). Sunitinib is recognized as an effective drug in suppressing cell proliferation and angiogenesis due to its potential antineoplastic action. Sunitinib capsules are used to treat pancreatic neuroendocrine tumors, renal cancer, and gastrointestinal stromal tumors (GIST). Sunitinib was the first cancer treatment to be licensed for two indications at the same time: renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor (GIST). The global sunitinib malate market is primarily driven by technological advancements and the rising prevalence of pancreatic cancer. Pancreatic cancer's rising prevalence is a primary driver of the worldwide sunitinib capsules market. According to the American Cancer Society, over 56,000 Americans will be diagnosed with pancreatic cancer in 2017, with over 42,000 of them anticipated to die by pancreatic cancer. Pancreatic tumors are more difficult to diagnose and remove than other tumors due to their relative inaccessibility. As a result, sunitinib malate capsules are increasingly being used to treat pancreatic cancers. However, higher cost of research and development(R&D), and high cost of sutent may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Sunitinib malate market is considered for the key regions such as North America Asia Pacific, , Latin America, Europe, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to rising prevalence of pancreatic cancer in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to growing awareness about pancreatic cancer in developing economies such as India, China, and others.

Major market player included in this report are:

Pfizer Incorporation

Topcarepharm

Njfirstpharm

J&K Scientific

Targetmol

Synthland Ltd

Teva Pharmaceutical Industries Ltd.

Astellas Pharma, Inc.

Dendreon Corporation

Ferring Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Purity: >99%

Purity: >98%

Purity: >97%

By Application:

Pancreatic Neuroendocrine Tumors

Kidney Cancer

Gastrointestinal stromal tumor

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018-19

Base year – 2019-2020

Forecast period – 2021 to 2027.

Target Audience of the Global Sunitinib malate market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Sunitinib malate market , by Region, 2019-2027 (USD Billion)

1.2.2. Sunitinib malate market , by Type, 2019-2027 (USD Billion)

1.2.3. Sunitinib malate market , by Application, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Sunitinib malate market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Sunitinib malate market Dynamics

3.1. Sunitinib malate market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing prevalence of pancreatic cancer

3.1.1.2. Increasing prevalence of pancreatic neuroendocrine tumours

3.1.2. Market Restraint

3.1.2.1. High cost of Sutent

3.1.3. Market Opportunities

3.1.3.1. Increase in Pharmaceutical R&D Spending

Chapter 4. Global Sunitinib malate market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Sunitinib malate market , by Type

5.1. Market Snapshot

5.2. Global Sunitinib malate market by Type , Performance - Potential Analysis

5.3. Global Sunitinib malate market Estimates & Forecasts by Type 2018-2027 (USD Billion)

5.4. Sunitinib malate market , Sub Segment Analysis

5.4.1. Purity: >99%

5.4.2. Purity: >98%

5.4.3. Purity: >97%

Chapter 6. Global Sunitinib malate market , by Application

6.1. Market Snapshot

6.2. Global Sunitinib malate market by Application, Performance - Potential Analysis

6.3. Global Sunitinib malate market Estimates & Forecasts by Application 2018-2027 (USD Billion)

6.4. Sunitinib malate market , Sub Segment Analysis

6.4.1. Pancreatic Neuroendocrine Tumors

6.4.2. Kidney Cancer

6.4.3. Gastrointestinal stromal tumor

Chapter 7. Global Sunitinib malate market , Regional Analysis

7.1. Sunitinib malate market , Regional Market Snapshot

7.2. North America Sunitinib malate market

7.2.1. U.S. Sunitinib malate market

7.2.1.1. Type breakdown estimates & forecasts, 2018-2027

7.2.1.2. Application breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Sunitinib malate market

7.3. Europe Sunitinib malate market Snapshot

7.3.1. U.K. Sunitinib malate market

7.3.2. Germany Sunitinib malate market

7.3.3. France Sunitinib malate market

7.3.4. Spain Sunitinib malate market

7.3.5. Italy Sunitinib malate market

7.3.6. Rest of Europe Sunitinib malate market

7.4. Asia-Pacific Sunitinib malate market Snapshot

7.4.1. China Sunitinib malate market

7.4.2. India Sunitinib malate market

7.4.3. Japan Sunitinib malate market

7.4.4. Australia Sunitinib malate market

7.4.5. South Korea Sunitinib malate market

7.4.6. Rest of Asia Pacific Sunitinib malate market

7.5. Latin America Sunitinib malate market Snapshot

7.5.1. Brazil Sunitinib malate market

7.5.2. Mexico Sunitinib malate market

7.6. Rest of The World Sunitinib malate market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Pfizer Incorporation

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Topcarepharm

8.2.3. Njfirstpharm

8.2.4. J&K Scientific

8.2.5. Targetmol

8.2.6. Synthland Ltd

8.2.7. Teva Pharmaceutical Industries Ltd.

8.2.8. Astellas Pharma, Inc.

8.2.9. Dendreon Corporation

8.2.10. Ferring Pharmaceuticals, Inc.

Chapter 9. Research Application

9.1. Research Application

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Sunitinib malate market , report scope

TABLE 2. Global Sunitinib malate market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Sunitinib malate market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 4. Global Sunitinib malate market estimates & forecasts by Application 2018-2027 (USD Billion)

TABLE 5. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Global Sunitinib malate market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 20. Global Sunitinib malate market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. U.S. Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. U.S. Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Canada Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Canada Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. UK Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. UK Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. Germany Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. Germany Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. France Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. France Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Spain Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Spain Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Italy Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Italy Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. ROE Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. ROE Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. China Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. China Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. India Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. India Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Japan Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Japan Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Australia Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Australia Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. South Korea Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 58. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 59. South Korea Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 60. ROPAC Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 61. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 62. ROPAC Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 63. Brazil Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 64. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 65. Brazil Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 66. Mexico Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 67. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 68. Mexico Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 69. ROLA Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 70. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 71. ROLA Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 72. ROW Sunitinib malate market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 73. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 74. ROW Sunitinib malate market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 75. List of secondary sources used in the study of global Sunitinib malate market .

TABLE 76. List of primary sources used in the study of global Sunitinib malate market .

TABLE 77. Years considered for the study.

TABLE 78. Exchange rates considered.

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global Sunitinib malate market Size study, by Type (Purity: >99%, Purity: >98%, Purity: >97%), by Application (Pancreatic Neuroendocrine Tumors, Kidney Cancer, Gastrointestinal stromal tumor) and Regional Forecasts 2021-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara